Sunday
June 20 2021
9:37 AM
banner-icon1 banner-icon2 banner-icon3

Local Oregon News

Local News Index


Previous story Oregon Woman Dies After Getting J&J vaccine, CDC investigating Next story
  Six other reports of the unusual clots, including a death, out of more 8 million   The unidentified woman received the dose before the CDC ordered a pause on the vaccine  


Story by Gordon Grearson - The Oregon Herald
Published on Friday April 23, 2021 - 4:58 AM
 
Share on Facebook Share on Twitter
PORTLAND, Oregon - The Centers for Disease Control and Prevention is investigating the death of a woman who was living in Oregon after being given the Johnson & Johnson's COVID vaccine. The Oregon woman in her 50s developed a rare blood clot before two weeks of receiving the Johnson & Johnson vaccine.

Health officials learned of the investigation on Tuesday, two days after the U.S. Centers for Disease Control and Prevention began the investigation, the agency said. The unidentified woman received the dose before the CDC ordered a pause on the vaccine amid concerns it could cause dangerous clots. Six reports of the unusual clots, including a death, out of more 8 million

She developed a rare blood clot. Dr. Shimi Sharief, senior health advisor for Oregon's health authority, said the woman's symptoms were consistent with other cases; abdominal pain, severe headache, leg pain, and shortness of breath.

It is not clear when the woman got the vaccine or where in Oregon she lived, citing patient privacy. The woman was hospitalized before her death and got the vaccine in early April.

Until the investigation is complete, which health officials predict will take a week or more, it's not certain that her death is related to the vaccine, the agency said.

Federal and state agencies paused the J&J vaccine rollout on April 13 due to concerns about blood clots.

"For most people that received the (J&J) vaccine, we are nearing the end of that time of where they need to be monitoring for symptoms," Sharief said. The CDC warned that if people have symptoms within three weeks after receiving the vaccine they should contact their health care provider.

Federal officials already were examining six reports of the unusual clots, including a death, out of more 8 million Americans given the one-dose vaccination so far.

The CDC also told Texas health authorities Thursday that a woman in that state was hospitalized with possible blood clots associated with J&J vaccine recipients.

A recommendation could be made soon whether and how to resume use of the J&J vaccine. Information about the death that occurred this week has been sent to the CDC through the Vaccine Adverse Event Reporting System (VAERS), the national reporting system used to collect reports of adverse events after vaccination.

OHA was notified of the possible adverse event on April 20, two days after the CDC was notified on April 18.

Sharief said whether Oregon resumes distribution of the J&J vaccine will be a "reflection" of the committee's decision.

"We have the utmost confidence that it would be a decision made with thorough investigation and consideration of the potential benefits and risks, in relation to each other, as we go through this pandemic," Sharief said.